Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Seer, Inc. develops innovative proteomics solutions leveraging engineered nanoparticle technology to enable deep, unbiased, large-scale analysis of the proteome. Its Proteograph Product Suite includes consumables, automation, and software for rapid, high-throughput peptide-level proteomic profiling across diverse biofluids and species. The company's platform supports biomarker discovery, proteogenomics, translational research, and clinical applications, advancing precision medicine and biological understanding through scalable, reproducible, and comprehensive proteomic data.
This description was generated via AI from an annual report. Updated about 1 year ago.